Jennison Associates

Jennison Associates has earned a reputation for excellence by fulfilling client investment needs since its founding in 1969.

Business Model:

Revenue: $100M

Employees: 201-500

Rankings

Detailed Jennison Associates Information

Geographic Data

Jennison Associates headquarters map

Address: 466 Lexington Ave

City: New York

State: NY

Zip: 10017

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

2,030,572Website Global Rank

10,145Website Monthly Traffic

Twitter Followers

Description

Jennison Associates has earned a reputation for excellence by fulfilling client investment needs since its founding in 1969. Today, the firm manages over $93 billion for institutions and private clients through separately managed accounts and commingled vehicles, including mutual funds through subadvisory relationships.

Contact Phone:
+12124211000

Contact Email:

Announced Date Company Transaction Money Raised
4/2011 Merrimack Pharmaceuticals Private Equity Round 0
4/2006 Merrimack Pharmaceuticals Series E 0
8/2006 ChemoCentryx Series C 0
7/2015 GenSight Biologics Series B 0
1/2015 Aduro BioTech Series D 51.4M
3/2015 Aeglea BioTherapeutics Series B 44M
10/2005 Avanir Pharmaceuticals Post-IPO Equity 16.2M
4/2015 Natera Series F 0
4/2015 Dimension Therapeutics Series B 65M
8/2015 Syndax Pharmaceuticals Series C 0
1/2021 Clover Health Post-IPO Equity 400M
6/2015 Cogent Biosciences Series B 65M
3/2013 PTC Therapeutics Private Equity Round 60M
8/2014 Bellicum Pharmaceuticals Series C 55M
6/2021 Electric Last Mile Solutions Post-IPO Equity 0
9/2014 Flex Pharma Venture Round 0
4/2014 Otonomy Series D 49M
11/2014 Nivalis Therapeutics Venture Round 30M
8/2015 Editas Medicine Series B 0
6/2021 Talkspace Post-IPO Equity 0
8/2015 Wave Life Sciences Series B 66M
8/2015 Ovid Therapeutics Series B 75M
9/2018 Allogene Convertible Note 0
5/2015 REGENXBIO Series D 0
3/2021 Field Trip Health Post-IPO Equity 0
10/2011 Puma Biotechnology Post-IPO Equity 55M
7/2015 Afferent Pharmaceuticals Series C 55M
6/2021 Electric Last Mile Solutions Post-IPO Equity 0
6/2021 Talkspace Post-IPO Equity 0
3/2021 Field Trip Health Post-IPO Equity 0
1/2021 Clover Health Post-IPO Equity 0
9/2018 Allogene Therapeutics Convertible Note 0
8/2015 Syndax Pharmaceuticals Series C 0
8/2015 Wave Life Sciences Series B 0
8/2015 Ovid Therapeutics Series B 0
8/2015 Editas Medicine Series B 0
7/2015 GenSight Biologics Series B 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research